Skip to main content
Midas Edge

Guardant Health, Inc.

For the period ended Jun 30, 2025. Filed Jul 30, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Jul 30, 2025

GH$155.35-2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (unaudited)

(in thousands, except share data)

Three Months Ended June 30, 2025
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Deficit
Shares · Amount · Treasury Stock
Balance as of April 1, 2025123,647,166$1$(45,010)$2,472,272$(4,658)$(2,673,394)$(250,789)
Issuance of common stock upon exercise of stock options58,912——1,557——1,557
Vesting of restricted stock units461,439——————
Common stock issued under employee stock purchase plan310,387——7,680——7,680
Employee taxes paid related to net share settlement of restricted stock units———(7,421)——(7,421)
Stock-based compensation———42,462——42,462
Other comprehensive income————935—935
Net loss—————(99,899)(99,899)
Balance as of June 30, 2025124,477,904$1$(45,010)$2,516,550$(3,723)$(2,773,293)$(305,475)
Three Months Ended June 30, 2024
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Equity (Deficit)
Shares · Amount
Balance as of April 1, 2024121,787,297$1$2,329,930$(4,799)$(2,256,847)$68,285
Issuance of common stock upon exercise of stock options540,561—2,364——2,364
Vesting of restricted stock units269,896—————
Common stock issued under employee stock purchase plan371,826—7,212——7,212
Employee taxes paid related to net share settlement of restricted stock units——(3,240)——(3,240)
Stock-based compensation——27,235——27,235
Other comprehensive loss———(841)—(841)
Net loss————(102,628)(102,628)
Balance as of June 30, 2024122,969,580$1$2,363,501$(5,640)$(2,359,475)$(1,613)
Six Months Ended June 30, 2025
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Deficit
Shares · Amount · Treasury Stock
Balance as of January 1, 2025123,994,006$1$—$2,443,788$(5,201)$(2,578,235)$(139,647)
Issuance of common stock upon exercise of stock options103,033——2,325——2,325
Vesting of restricted stock units1,046,829——————
Common stock issued under employee stock purchase plan310,387——7,680——7,680
Employee taxes paid related to net share settlement of restricted stock units———(22,918)——(22,918)
Stock-based compensation———80,219——80,219
Repurchase of treasury stock(976,351)—(45,010)———(45,010)
Unwinding of convertible note hedges———5,456——5,456
Other comprehensive income————1,478—1,478
Net loss—————(195,058)(195,058)
Balance as of June 30, 2025124,477,904$1$(45,010)$2,516,550$(3,723)$(2,773,293)$(305,475)
Six Months Ended June 30, 2024
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Equity (Deficit)
Shares · Amount
Balance as of January 1, 2024121,629,861$1$2,304,220$(3,675)$(2,141,862)$158,684
Issuance of common stock upon exercise of stock options577,352—2,577——2,577
Vesting of restricted stock units390,541—————
Common stock issued under employee stock purchase plan371,826—7,212——7,212
Employee taxes paid related to net share settlement of restricted stock units——(4,784)——(4,784)
Stock-based compensation——54,276——54,276
Other comprehensive loss———(1,965)—(1,965)
Net loss————(217,613)(217,613)
Balance as of June 30, 2024122,969,580$1$2,363,501$(5,640)$(2,359,475)$(1,613)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.